| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |